Background {#Sec1}
==========

Fluid therapy is a key part of resuscitation of the shocked patient in the Emergency Department (ED). Prompt and effective fluid resuscitation is required to prevent grave outcomes \[[@CR1], [@CR2]\]. However, excessive fluid has been associated with increased complications, length of hospital stay and mortality \[[@CR3]--[@CR7]\]. Titration of fluid therapy and the stratification of patients into those who will benefit and those who may be harmed is a clinical dilemma that confronts emergency physicians on a daily basis.

Fluid resuscitation is currently delivered with uncertainty and variability. There is uncertainty about the amount to give and when to stop. There is significant individual variation in the amount of fluid given between patients, especially in the elderly. This variation was evident in recent major clinical trials where the total volume of intravenous (IV) fluid therapy in ED varied from 200 ml to over 10,000 ml \[[@CR8]--[@CR10]\].

Pre-existing medical conditions or acute disease associated myocardial dysfunction alter the response to resuscitation. Critical care studies demonstrate that only half of haemodynamically unstable patients in intensive care units (ICUs) respond to fluid therapy \[[@CR11]\]. It is likely that less than 40% of hypotensive patients with sepsis respond to fluid therapy \[[@CR12], [@CR13]\]. These patients can be harmed by excess fluid, as it may contribute to endothelial injury, organ dysfunction and increased morbidity and mortality \[[@CR14]--[@CR18]\]. 'One-size-fits-all' protocols are offered to initiate therapy \[[@CR12]\], but do not solve the conundrums of continuing fluid management.

In ED, resuscitation remains largely guided by clinical examination, basic monitoring parameters (e.g. blood pressure and heart rate) and biochemical parameters (e.g. blood lactate), which are poor predictors of volume status \[[@CR19], [@CR20]\]. While change in central venous pressure (CVP) is still widely used, it has poor relationship with volume status \[[@CR21], [@CR22]\].

The immediate goal of fluid resuscitation is improving cardiac output (CO) and ultimately improving tissue perfusion. If a fluid bolus does not increase CO, it will not improve tissue perfusion and may be harmful. The haemodynamic response to fluid loading, 'fluid responsiveness' has been suggested as a dynamic guide for fluid therapy and a controlled method of resuscitation \[[@CR23]\]. Testing fluid responsiveness involves both a fluid challenge, and subsequent monitoring of change in a haemodynamic parameter \[[@CR18]\].

One suggested definition of fluid responsiveness is 'an increase in a physiologic parameter, preferably cardiac output, within 15 min, superseding twice the error of the measuring technique after a 15-min administration of 6 mL/kg of crystalloids' \[[@CR24]\]. However there is little agreement on the type or amount of fluid to use, the rate of infusion or the physiological targets \[[@CR25]\]. The main drawback of using a fluid challenge is that, if it is negative, fluid has been irreversibly administered to the patient.

Alternatively, the preload challenge can be by passive leg raise (PLR) \[[@CR26]\] or positive pressure ventilation \[[@CR27]\]. PLR has been used as a transient and reversible self-fluid challenge \[[@CR26]\]. During PLR, recruitment of splanchnic and lower limb blood transfers a volume of around 300 mL of blood into the central circulation mimicking a fluid challenge \[[@CR28]\]. The effect of PLR is transient reaching its maximum effect at approximately 1 min \[[@CR29]\]. The final type of preload challenge is to use the circulatory effects of pressure cycles during mechanical ventilation, however this technique is not applicable to the majority of spontaneously breathing patients in ED \[[@CR27]\].

A number of less invasive and noninvasive techniques for haemodynamic monitoring have been developed, which may be appropriate in emergency care. Less invasive methods include trans-oesophageal Doppler, transpulmonary thermodilution, pulse contour and pulse power analysis. Noninvasive methods include end-tidal carbon dioxide, transthoracic Doppler, bioimpedance, plethysmography and bioreactance \[[@CR30]\].

Most of the evidence about different fluid responsiveness strategies comes from perioperative and critical care setting, however as anaesthesia and ventilation profoundly affect cardiovascular responses, these data are difficult to apply to the ED. There are no previous systematic reviews on this topic in ED. In this study, we aim to synthesise the existing literature investigating fluid responsiveness in in-hospital emergency care.

Methods {#Sec2}
=======

A systematic review of literature was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement \[[@CR31]\].

PICO statement {#Sec3}
--------------

Patient, In adult patients who may need fluid resuscitation in ED,

Intervention, Does testing fluid responsiveness

Comparison, Compared to standard care

Outcome, Affect haemodynamic or biochemical parameters, resource utilisation or mortality?

Identification of records {#Sec4}
-------------------------

We searched the US National Library of Medicine's MEDLINE database via Ovid interface, Embase and the Cochrane library for relevant peer-reviewed studies published from 1946 to present. A clinical librarian assisted in the literature search.

We used the following search terms and subject headings: "emergency", "fluid/preload or volume responsiveness" and "preload dependency" with appropriate variations where applicable (Table [1](#Tab1){ref-type="table"}). The references of identified articles were used to identify further publications. An electronic search alert was set up to identify recently published studies. Retrieved results were transferred to Endnote® (Thomson Reuters) where duplicates were removed. Titles were screened for relevance initially, and abstracts were then further assessed. The full-text of eligible articles was obtained from NHS Athens and they were assessed for relevance. A flow diagram summarises the screening process (Fig. [1](#Fig1){ref-type="fig"}).Table 1Search strategy, Embase: 1974 -- 20 June 2016Search termResults1exp EMERGENCY HEALTH SERVICE/779072exp EMERGENCY MEDICINE/330703exp EMERGENCY WARD/856834"emergency department\*".ti,ab870765"emergency room\*".ti,ab228196(accident\* adj2 emergenc\*).ti,ab52547("cardiac output\*" adj2 increas\*).ti,ab68498("stroke volume\*" adj2 increas\*).ti,ab24339"emergency care".ti,ab7924101 OR 2 OR 3 OR 4 OR 5 OR 6 OR 921483011"pre load dependen\*".ti,ab712"preload dependen\*".ti,ab24113"fluid challeng\*".ti,ab78314"fluid respon\*".ti,ab122515"pre load respon\*".ti,ab016"preload respon\*".ti,ab11717"volume respon\*".ti,ab1186187 OR 8 OR 11 OR 12 OR 13 OR 14 OR 15 OR 16 OR 17116721910 AND 18248 Fig. 1Screening process

Critical appraisal {#Sec5}
------------------

Critical appraisal of the studies identified as relevant to the PICO question followed the CONSORT statement for randomized studies and the STARD checklist for diagnostic accuracy studies.\[[@CR32], [@CR33]\] Two authors (M.H.E and T.J.C) independently evaluated the methodologic quality of included studies and discussed the results. A third reviewer was available if a common rating was not agreed. Each study was rated according to the Oxford Clinical Evidence Based Medicine (OCEBM) levels of evidence \[[@CR34]\].

Results {#Sec6}
=======

A total of 249 publications were retrieved of which 22 studies underwent full-text review. Eight relevant studies were identified, with characteristics shown in Table [2](#Tab2){ref-type="table"}, all of which were appraised as containing low level evidence. Twelve relevant conference abstracts were retrieved, however, we decided to exclude them as there was insufficient data to evaluate quality, and no subsequent full-text publications. Only 3 studies addressed clinical outcomes - including 2 randomised controlled trials (RCT) and one feasibility study (Table [3](#Tab3){ref-type="table"}) \[[@CR35]--[@CR37]\]. Five articles evaluated the diagnostic accuracy of fluid responsiveness techniques in ED (Table [4](#Tab4){ref-type="table"}) \[[@CR38]--[@CR42]\]. Neither diagnostic studies nor the feasibility study included a comparison to standard care. The two RCTs varied in patient groups, interventions and primary outcomes. Due to marked heterogeneity, it was not possible to combine results in a meta-analysis. In the following paragraphs, we elaborate on the findings of the two RCTs and the two highest quality diagnostic studies.Table 2General characteristics of included studiesAuthorYearLocationSettingDesignAimsLevel of evidence\*Appraisal commentsCorl^38^2012USASingle centre, academic EDDiagnosticTo determine the accuracy of the caval index to detect fluid responsiveness4• High risk of bias\
• Convenience sample, unclear description of population\
• Gold standard (TEB) questionable\
• Patients were excluded from analysis due to incomplete dataJung^42^2012KoreaSingle centre, academic EDDiagnosticTo determine the validity of corrected flow to predict fluid responsiveness4• High risk of bias\
• Not presented as a diagnostic test study\
• Unclear patient selection method\
• No blinding to reference test measurements.\
• No pre-specified thresholdFeissel^40^2013FranceSingle centre, EDDiagnosticTo determine whether plethysmographic variability index can predict\
fluid responsiveness3• High risk of bias\
• Not presented as a diagnostic test study\
• Unclear patient selection method.\
• Inappropriate exclusions\
• Patients were excluded from analysis due to incomplete data\
• No pre-specified thresholdCoen^37^2014ItalySingle centre, major metropolitan EDTreatmentTo investigate the reliability of caval index and lung ultrasound to guide fluid infusion4• High risk of bias\
• No control group\
• No sample size calculationde Valk^39^2014NetherlandsSingle centre, academic EDDiagnosticTo investigate the reliability of caval index to predict fluid responsiveness4• High risk of bias\
• Convenience sample\
• No pre-specified threshold.\
• Gold standard test questionable\
• No blinding to index test measurements\
• Patients were excluded from analysis due to incomplete data\
• No pre-specified thresholdDuus^41^2015USASingle centre, adult EDDiagnosticTo determine the reproducibility of PLR and fluid bolus monitored by bioreactance in predicting fluid responsiveness3• High risk of bias\
• Observational\
• Convenience sample.\
• Consecutive measures may influence each other\
• No blinding to index test measurementsHou^36^2016USAMulti centreTreatment\
(RCT)To evaluate the impact of a fluid responsiveness protocol in decreasing organ failure4• Lack of blinding\
• Relatively few patients per center\
• Only collected 10% of planned sample. Very likely Type II error\
• Downgraded due to imprecisionKuan^35^2016SingaporeSingle centre, academic EDTreatment\
(RCT)To Evaluate a non-invasive heamodynamic algorithm compared to standard care2• Lack of blinding\
• Underpowered: high difference in primary outcome -- ARR 25%. RRR approx. 40%RCT, Randomised controlled trial; TEB, thoracic electrical bioimpedance; ARR, absolute risk reduction; RRR, relative risk reduction; ED, emergency department; PLR, passive leg raise Table 3Main characteristics of clinical studiesAuthorParticipantsInterventionControlPrimary outcomeInclusion criterianSOFABasline MAPBaseline lactateDynamic testMonitorParameter measuredCutoffTreatmentKuan^35^Age ≥21, two SIRS criteria, suspected infection and lactate ≥ 3 mmol/L1223.4 ± 2.6\*88 ± 18\*4.8 ± 2\*PLRBioreactance∆SVI10%500 mL bolusStandard care (target MAP \> =65)Rate of lactate clearance \>20% at 3 h20%1 L bolusHou^36^Age ≥18, two SIRS criteria, lactate ≥2 mmol/L and \< 4 mmol/L and 4 h from ED presentation641.1 ± 1.5\*92\*2.6 ± 0.4\*Fluid bolus (5 ml/kg over 10 min)Bioreactance∆SV\
(within 5 min of the fluid bolus)10%1 L infusionStandard careWorsening SOFA score by \> =1 point over the first 72 hCoen^37^Age ≥18, Septic shock or Lactate \>4 mmol/L517.1 ± 2.960 ± 134.6 ± 3.3Spontaneous breathingUltrasoundCaval index30%500 mL bolusN/AN/A\*Combined from treatment and control groups estimatesSIRS, systemic inflammatory response syndrome; SOFA, sequential organ failure assessment; MAP, mean arterial pressure; PLR, passive leg raise; SVI, stroke volume index; SV, stroke volume Table 4Summary of diagnostic accuracy studiesAuthorParticipantsInterventionCriterion standard (FR definition)Rate of FR (%)SNSPAUCInclusion criteriaNo.Disease severityBase BPBase LactateSpont. breathingDynamic testMonitorParameter measuredCutoffCorl^38^Age ≥18, clinically expected to be eu- or hypovolaemic26N/ASBP 114N/AYesPLRU/S∆ Caval indexN/A≥10% increase in CI by TEB 4 min after PLR31N/AN/A0.56 (0.31--0.81)Duus^41^Age ≥18 and decided to receive a fluid bolus109\
(100 were analysed)APACHE II 5 ± 3.6MAP 126 ± 191.4 ± 0.6YesPLRBioreactance∆SV10%≥10% increase in SV by bioreactance after a fluid bolus (at least 5 ml/kg -- no pre-defined infusion time or time frame for assessment)6080% (72%-88%)61% (51%-71%)N/Ade Valk^39^At least one clinical sign of shock and decided to receive a fluid bolus52 (45 were analysed)N/AMAP 73.8 ± 14.21,9 ± 1.1YesSpontaneous breathingU/SCaval Index36.5%\
(Not pre-defined)≥10 mmHg increase in BP 15 min after a fluid bolus (500 ml NaCl 0.9% over 15 min)2783%67%0.741Feissel^40^Age ≥18, mechanically ventilated, sinus rhythm and septic shock39 (31 were analysed)SOFA 14 ± 272 ± 19\*N/ANoMVPlethysmographyPlethysmographic variability index (PVI)19%\
(Not pre-defined)≥15% increase in VTI by TTE 5 min after a fluid bolus (8 mL/kg HES over 20 min)5294% (69%-100%)87% (61%-97%)0.97 (0.83-0.99)Jung^42^Spontaneous breathing, sepsis-induced hypotension26 (22 were analysed)N/AN/AN/AYesNoneOesophageal DopplerBaseline corrected flow time (FTc)301 ms\
(Not pre-defined)≥10% increase in SVI by oesophageal Doppler immediately after a fluid bolus (7 mL/kg HES over 30 min)6588.2%88.8%0.870 (0.708--0.979)\*Combined from responders and non-responders estimatesBP, blood pressure; FR, fluid responsiveness; SN, sensitivity; SP, specificity; AUC, area under the curve; PLR, passive leg raise; SVI, stroke volume index; SV, stroke volume; U/S, ultrasound; SOFA, sequential organ failure assessment; SBP, systolic blood pressure; MAP, mean arterial pressure; APACHE, Acute Physiology and Chronic Health Evaluation; MV, mechanical ventilation; CI, cardiac index; VTI, velocity time integral; TTE, trans-thoracic echocardiography; HES, hydroxylethyl starch

Kuan et al.\[[@CR35]\] compared a fluid responsiveness protocol to standard care. Inclusion criteria were sepsis (defined by two systemic inflammatory response syndrome, SIRS, criteria and suspected infection) and lactate ≥3 mmol/L. Fluid responsiveness was estimated by change in stroke volume index (∆SVI) measured by bioreactance CO monitor after PLR. A positive response (defined as 10%--20% ∆SVI) triggered infusion of 500 mL or 1 L of crystalloids respectively. The primary outcome was lactate clearance of more than 20% at 3 h. Initial fluid responsiveness was observed in 79% of treatment group patients. The treatment group received clinically significant more IV fluid (975 mL; 95% CI−450 to 1,725 mL) by the end of study at 3 h, but there was no significant difference in the rate of lactate clearance at 3 h or in-hospital mortality. Both groups received comparable amount of fluid at 24 h. In a planned subgroup analysis of patients with pre-existing fluid overload (e.g. congestive heart failure and renal failure), fluid responsiveness group received more fluid at 3 h.

Hou et al. \[[@CR36]\] compared standard care to a fluid responsiveness protocol using a fluid bolus and bioreactance CO monitor. Inclusion criteria were age ≥18, two SIRS criteria, lactate ≥2 mmol/L and \< 4 mmol/L and 4 h from ED presentation. Fluid responsiveness, defined as \>10% increase in stroke volume (SV) after a 5 mL/Kg fluid bolus, mandated 1 L of fluid infusion. The primary outcome was change of sequential organ failure assessment (SOFA) score ≥1 over 72 h. The rate of fluid responsiveness was 47%. There was no significant difference in increase in SOFA score, the rate of hospitalisation or change in lactate over 4 h. The treatment group received significantly more IV fluid at 4 h 2633 cc (2264 -- 3001) vs 1002 cc (707 -- 1298), however the amount of fluid received was similar at 24 h.

Duus et al. \[[@CR41]\] evaluated the diagnostic accuracy of PLR compared to fluid bolus - both measured by bioreactance. Fluid responsiveness was defined as ≥10% increase in SV after a fluid bolus. The rate of fluid responsiveness was 60%. PLR predicted fluid responsiveness with a sensitivity of 80% (72%--88%) and specificity of 61% (51%--71%). All patients were spontaneously breathing and most were of low disease severity (Table [4](#Tab4){ref-type="table"}).

Feissel et al. \[[@CR40]\] evaluated Plethysmographic variability index (PVI) during mechanical ventilation compared to an 8 mL/kg hydroxylethyl starch bolus. Fluid responsiveness was defined as ≥15% increase in velocity time integral (VTI) by echocardiography after the fluid bolus. Fluid responsiveness was detected in 52% of patients. PVI predicted the response to fluid loading with a sensitivity of 94% (69%--100%), specificity of 87% (61%--97%) and area under the curve (AUC) of 0.97 (0.83--0.99) (Table [4](#Tab4){ref-type="table"}).

Limitations {#Sec7}
-----------

This is the first review of fluid responsiveness in emergency medicine, and has a number of limitations. This review was not registered in advance, which may increase the risk of reporting bias. Literature search was undertaken by one author (M.H.E.), however, a clinical librarian was involved in the search strategy. We used wide search criteria from three sources and hand searched references to include relevant studies, however we excluded conference abstracts that could not be assessed for methodological quality.

Discussion {#Sec8}
==========

While fluid responsiveness is directly relevant to emergency care, we have found very little evidence (489 patients in total) on which to base best practice. This small number of studies reflects a relatively new concept to emergency care compared to anaesthesia and critical care - where fluid therapy has evolved over many years \[[@CR11], [@CR43]\]. Most studies suffered from methodological limitations and there was a large amount of heterogeneity, which makes interpretation difficult.

The main sources of heterogeneity were (1) the patient groups, (2) the type of preload challenge, (3) the monitoring method used, and (4) the definition of 'fluid responsive'.

Patients {#Sec9}
--------

Patients included in the studies had a wide range of underlying conditions of varying severity. In contrast with ICU and peri-operative studies \[[@CR44]\], most patients were spontaneously breathing (except the Feissel et al. \[[@CR40]\] study of mechanically ventilated patients in ED). The 2 RCTs were based on less severe patients in early sepsis, with both studies having low generalizability as they excluded patients with a wide range of comorbid conditions. In both studies patient inclusion hinged mainly on the diagnosis of sepsis and elevated lactate. However, intensive fluid therapy based on lactate alone may not be appropriate \[[@CR45]\]. There is no clear signal from the evidence about whether future research should concentrate on high risk or lower risk patients.

Preload challenge {#Sec10}
-----------------

To give a preload challenge three studies used PLR \[[@CR35], [@CR38], [@CR41]\], one study used a fluid challenge, \[[@CR36]\] two used the spontaneous breathing effect \[[@CR37], [@CR40]\],one used mechanical ventilation \[[@CR40]\] and one did not use a preload challenge and relied on baseline measurements \[[@CR42]\]. These methods are not necessarily comparable, and there is little evidence about which is best in ED.

Fluid bolus has been used as the criterion method (gold standard) of preload challenge in all but one diagnostic studies \[[@CR39]--[@CR42]\]. The fluid challenge varied in type, amount, infusion time and time frame for assessment (Table [4](#Tab4){ref-type="table"}). Similar variability was reported in ICU practice \[[@CR46]\] and in similar diagnostic studies where fluid challenge was used as a criterion standard \[[@CR44], [@CR47]\]. A recent review showed heterogeneity in fluid bolus therapy and a lack of studies correlating the physiological effects of a fluid bolus to clinical outcomes \[[@CR25]\].

Monitoring {#Sec11}
----------

Most of the included studies tested non-invasive monitors to track CO (or one of its surrogates). This is in line with a recent French survey that demonstrated that ED clinicians prefer to use the less invasive and less time-consuming indicators of fluid responsiveness \[[@CR48]\]. In our review bioreactance was employed in 3 studies \[[@CR35], [@CR36], [@CR41]\], ultrasound derived caval index in 3 studies \[[@CR37]--[@CR39]\] and plethysmography in one study \[[@CR40]\]. One study used oesophageal Doppler in the ED, but this is probably too invasive to be generalizable \[[@CR42]\].

In the diagnostic accuracy studies (Table [4](#Tab4){ref-type="table"}), the variation in definition of the criterion standard made comparison difficult. Two studies utilised the same monitor for both the test and reference methods \[[@CR41], [@CR42]\] (one using bioreactance and the other oesophageal Doppler) violating the assumption of independence and leading to risk of overestimation of effect \[[@CR41], [@CR42]\]. The remaining 3 studies each used a different reference test, (one each using bioimpedance, non-invasive blood pressure and trans-thoracic echocardiography).

Fluid responsiveness definition {#Sec12}
-------------------------------

There was a variety of definitions used to define 'fluid responsive'. The commonest definition of fluid responsiveness was a 10% increase in SV, cardiac index (CI) or SVI (5 studies) \[[@CR35], [@CR36], [@CR38], [@CR41], [@CR42]\]. Caval index, blood pressure and echocardiographic velocity time integral (VTI) were used in the remaining 3 studies. Using these different definitions and the varying entry criteria the rate of fluid responsiveness in the patients studied ranged from 31% to 79%.

Previous studies, mostly in ICU, used \>0 to 20% change in SV or CO as a threshold for fluid responsiveness \[[@CR11]\]. More recently this range has narrowed with a 10--15% change commonly used to define a change that is not due to random variability \[[@CR49]\]. This cut-off is sometimes derived from the reported precision of thermodilution \[[@CR50]\], and may not be optimal when a different device is used \[[@CR51]\]. The clinical significance of a given change should be also appreciated.

Diagnostic accuracy {#Sec13}
-------------------

The diagnostic accuracy of different techniques varied greatly (Table [4](#Tab4){ref-type="table"}). This may be explained by the heterogeneity of subjects and methods or by true differences between the techniques. Notably, the highest accuracy was observed in mechanically ventilated patients, \[[@CR40]\] which may show the technical challenge of applying fluid responsiveness to spontaneously breathing and moving patients in ED.

The diagnostic accuracy of different fluid responsiveness predictors have been more thoroughly studied in ICU and peri-operative setting. PLR-induced changes in CO has been validated against a 'gold standard' fluid bolus in several meta-analyses \[[@CR44], [@CR47], [@CR52], [@CR53]\]. It showed a reasonable accuracy regardless of the monitoring method or ventilation mode (sensitivity 85--89%, specificity 91--92% and area under the curve 0.95). Lower accuracy was observed for caval index, especially in spontaneously breathing patients - with a higher cut-off value to define a positive response \[[@CR54]\].

In ED patients, spontaneous breathing, arrhythmia and autonomic response to PLR may confound the validity of the test. The test may also be different in ED patients who may be more hypovolaemic in the early stages of treatment, compared to the more fluid replete patients in ICU. The accuracy of the caval index remains questionable in spontaneously breathing patients \[[@CR54]\], and the methods based on mechanical ventilation (e.g. plethysmography) are only relevant to a few of the most severely ill ED patients \[[@CR55]\].

Outcomes {#Sec14}
--------

One of the three clinical trials was a feasibility study without a primary outcome. The remaining two studies used different primary outcomes -- lactate clearance and SOFA score change (Table [3](#Tab3){ref-type="table"}). Both studies reported no significant difference in primary outcomes. However Type II error is possible, as the trial that used a clinically important endpoint (SOFA score at 72 h) only recruited 10% of the planned sample size, so the results cannot be interpreted \[[@CR36]\].

A secondary outcome for all studies was the amount of fluid given. The fluid responsiveness based protocols triggered more intensive early resuscitation, however the total fluid received by fluid responsiveness and standard care groups seemed to equalise by the end of the first 24 h. So, total fluid volume was the same, but the intervention meant that the fluid was 'front-loaded' into the early phase of care. A similar effect has been seen in the recent major protocolised sepsis care trials \[[@CR8]--[@CR10], [@CR56]\].

There are limited data on the usefulness of the fluid responsiveness approach to fluid management. A 2012 Cochrane review showed no mortality benefit from flow-guided haemodynamic approach in the peri-operative setting. This was supported by a recent RCT of a CO-guided haemodynamic algorithm (repeated 250 ml fluid challenges over 5 min. Fluid responsiveness was defined as ≥10% increase in SV sustained for 20 min or more) \[[@CR57]\]. There was no significant difference in morbidity or mortality. However, the authors went on to include their findings to an updated meta-analysis of 37 more trials and found fewer complications in the intervention arm.

Implications and uncertainties {#Sec15}
------------------------------

The clinical relevance of 'fluid responsiveness' in the ED may be similar in principle to other settings. However, fluid management in ED is faced with unique challenges (e.g. early disease, elderly patients), in addition to limited time, limited resources and sometimes delay in transfer to intensive care. Hence, studies in other settings may not resolve the ED haemodynamic dilemma. As the benefit of fluid administration is often related to early administration, we think that, despite the practical difficulties, studying fluid resuscitation in the ED is fundamental for improving patient outcomes. Fluid responsiveness based resuscitation strategies have not been adequately tested in the ED to know whether or not they influence outcome, but fluid responsiveness remains an attractive concept.

We were unable to perform any meta-analysis due to the large variation within the literature. To resolve the current heterogeneity, we would like to suggest some standardisation for future research:*Which patient group?*Standardised definition of the target patient group is required, and the 'uncertainty principle' could be used. It is unreasonable to delay fluid administration for overtly hypovolaemic or septic patients, and a fluid responsiveness test is not needed. It is also unreasonable to give fluid if the clinician thinks that this may be harmful. However, in patients where the clinician is uncertain about the best course of action a test of fluid responsiveness may help. Future research should target the groups where there is clinical uncertainty.*What is the target response?*It is difficult to interpret a diagnostic test when the target response is ill defined. Current theory suggests that fluid responsiveness is a normal state (normal hearts are functioning on the ascending limb of the Frank-Starling curve) \[[@CR23], [@CR58]\]. However, only about half of healthy volunteers show a positive fluid test response \[[@CR59]--[@CR61]\]. Other studies have shown that healthy supine adults do not increase their SV after a preload challenge \[[@CR62], [@CR63]\]. So either the test is not measuring what we think that it is measuring (other factors also influencing the test result) or the theoretic concept of 'normality' on the Frank-Starling curve is an over-simplification of complex cardiovascular physiology. It is therefore not correct (and a source of confusion in the current literature) to think of "responsiveness" as a target. Future studies should use an endpoint that is independent of the fluid responsiveness test.*What outcome should be used?*The outcome should be independent of the test and relevant to the patient. Survival (lived/died) is appropriate for large scale interventional clinical trials of a fluid responsiveness based resuscitation protocols. Surrogate outcomes should be carefully assessed for patient relevance. We would suggest that 'volume of fluid used' does not pass this test and should not be used as a primary outcome in future studies.*When to start and when to stop fluid resuscitation?*Fluid responsiveness does not tell us when to start or stop fluid therapy (about 50% of volunteers would have received unnecessary fluid based on a positive response). The human volunteer studies suggest that it may be unwise to use a fluid responsiveness test as a definition of the resuscitated state (an endpoint for resuscitation). A fluid responsiveness test may help the clinician decide if more fluid could help achieve the resuscitated state (by predicting the effect of a fluid bolus), but cannot be used to define when the resuscitated state has been achieved (for which there are already well established clinical parameters). Future studies should not use fluid responsiveness to determine when to start or stop fluid resuscitation.*What is the conceptual framework for fluid responsiveness in ED?*Much of the current heterogeneity within the literature seems to be based on different concepts of how a fluid responsiveness test could potentially be used in an ED management protocol. The key concept is that the test is only a predictor of the haemodynamic effect of further fluid resuscitation -- the clinician still has to decide whether further resuscitation is required and incorporate the fluid response prediction into the wider picture of the patient's physiological state. Future studies would have less variation if based around this central concept.

Conclusion {#Sec16}
==========

One-size-fits-all protocolised 'fixed goal' care has been challenged \[[@CR8]--[@CR10]\] and there is more interest in individualised care. The use of fluid responsiveness was investigated in the ED in 8 articles with considerable methodological heterogeneity. There were no high quality, adequately powered outcome studies so the place of fluid responsiveness in ED remains undefined. Future studies should have standardisation of patient groups, the target response and the underpinning theoretic concept of fluid responsiveness. The value of a fluid responsiveness based fluid resuscitation protocol in the ED needs to be established in a clinical trial.
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